Themis Medicare Limited

NSE THEMISMED.NS

Themis Medicare Limited Receivables for the year ending March 31, 2024: USD 21.33 M

Themis Medicare Limited Receivables is USD 21.33 M for the year ending March 31, 2024, a 20.91% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Themis Medicare Limited Receivables for the year ending March 31, 2023 was USD 17.65 M, a 33.23% change year over year.
  • Themis Medicare Limited Receivables for the year ending March 31, 2022 was USD 13.24 M, a 24.95% change year over year.
  • Themis Medicare Limited Receivables for the year ending March 31, 2021 was USD 10.60 M, a -22.06% change year over year.
  • Themis Medicare Limited Receivables for the year ending March 31, 2020 was USD 13.60 M, a 29.63% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
SV Wall Street
NSE: THEMISMED.NS

Themis Medicare Limited

CEO Dr. Sachin Dinesh Patel CChem., Ph.D.
IPO Date April 2, 2007
Location India
Headquarters 11/12 Udyog Nagar Industrial Estate
Employees 1,509
Sector Healthcare
Industries
Description

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.

Similar companies

SMSPHARMA.NS

SMS Pharmaceuticals Limited

USD 2.33

0.83%

RPGLIFE.NS

RPG Life Sciences Limited

USD 28.13

1.29%

TIIL.NS

Technocraft Industries (India) Limited

USD 30.75

1.73%

GUFICBIO.NS

Gufic Biosciences Limited

USD 5.19

6.71%

VENUSREM.NS

Venus Remedies Limited

USD 3.47

1.60%

StockViz Staff

February 2, 2025

Any question? Send us an email